Creative Planning’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.24M Buy
21,638
+2,693
+14% +$523K ﹤0.01% 1328
2025
Q4
$3.29M Sell
18,945
-300
-2% -$54.6K ﹤0.01% 1316
2025
Q3
$3.67M Buy
19,245
+1,994
+12% +$354K ﹤0.01% 1069
2025
Q2
$3.1M Buy
17,251
+1,842
+12% +$320K ﹤0.01% 1014
2025
Q1
$2.61M Buy
15,409
+34
+0.2% +$5.58K ﹤0.01% 1011
2024
Q4
$2.32M Buy
15,375
+3,783
+33% +$588K ﹤0.01% 1043
2024
Q3
$1.8M Buy
11,592
+185
+2% +$27.6K ﹤0.01% 1123
2024
Q2
$1.56M Buy
11,407
+1,929
+20% +$264K ﹤0.01% 1126
2024
Q1
$1.26M Sell
9,478
-33
-0.3% -$4.28K ﹤0.01% 1187
2023
Q4
$1.31M Buy
9,511
+1,071
+13% +$141K ﹤0.01% 1100
2023
Q3
$1.03M Sell
8,440
-428
-5% -$57K ﹤0.01% 1147
2023
Q2
$1.25M Buy
8,868
+348
+4% +$48K ﹤0.01% 1018
2023
Q1
$1.21M Sell
8,520
-1,000
-11% -$143K ﹤0.01% 981
2022
Q4
$1.49M Buy
9,520
+538
+6% +$77.3K ﹤0.01% 849
2022
Q3
$1.1M Buy
8,982
+257
+3% +$33.8K ﹤0.01% 928
2022
Q2
$1.16M Buy
8,725
+1,309
+18% +$178K ﹤0.01% 910
2022
Q1
$1.01M Buy
7,416
+8
+0.1% +$1.11K ﹤0.01% 973
2021
Q4
$1.28M Buy
7,408
+98
+1% +$14.9K ﹤0.01% 843
2021
Q3
$1.06M Buy
7,310
+291
+4% +$42.6K ﹤0.01% 918
2021
Q2
$926K Sell
7,019
-2,019
-22% -$264K ﹤0.01% 958
2021
Q1
$1.16M Buy
9,038
+214
+2% +$26.4K ﹤0.01% 953
2020
Q4
$1.05M Buy
8,824
+374
+4% +$45.6K ﹤0.01% 920
2020
Q3
$967K Sell
8,450
-540
-6% -$63.8K ﹤0.01% 816
2020
Q2
$1.02M Sell
8,990
-236
-3% -$25K ﹤0.01% 739
2020
Q1
$741K Buy
9,226
+1,056
+13% +$109K ﹤0.01% 766
2019
Q4
$872K Buy
8,170
+147
+2% +$15.3K ﹤0.01% 850
2019
Q3
$859K Sell
8,023
-367
-4% -$37.7K ﹤0.01% 823
2019
Q2
$854K Buy
8,390
+2,138
+34% +$205K ﹤0.01% 826
2019
Q1
$562K Sell
6,252
-305
-5% -$26.4K ﹤0.01% 972
2018
Q4
$546K Sell
6,557
-375
-5% -$35.2K ﹤0.01% 918
2018
Q3
$748K Buy
6,932
+1,545
+29% +$169K ﹤0.01% 881
2018
Q2
$592K Buy
5,387
+333
+7% +$34.7K ﹤0.01% 981
2018
Q1
$507K Sell
5,054
-881
-15% -$90.2K ﹤0.01% 1078
2017
Q4
$585K Sell
5,935
-586
-9% -$55.6K ﹤0.01% 985
2017
Q3
$611K Buy
6,521
+2,470
+61% +$262K ﹤0.01% 953
2017
Q2
$450K Sell
4,051
-108
-3% -$11.4K ﹤0.01% 1073
2017
Q1
$408K Buy
4,159
+980
+31% +$93.4K ﹤0.01% 1107
2016
Q4
$292K Sell
3,179
-402
-11% -$34.6K ﹤0.01% 1204
2016
Q3
$303K Buy
3,581
+1,609
+82% +$135K ﹤0.01% 1176
2016
Q2
$161K Buy
1,972
+234
+13% +$17.8K ﹤0.01% 1367
2016
Q1
$124K Buy
1,738
+173
+11% +$11.6K ﹤0.01% 1499
2015
Q4
$111K Sell
1,565
-15
-0.9% -$1.01K ﹤0.01% 1568
2015
Q3
$97K Buy
+1,580
New +$110K ﹤0.01% 1616
2015
Q2
Sell
-1,787
Closed -$137K 1543
2015
Q1
$137K Sell
1,787
-218
-11% -$15.6K ﹤0.01% 1396
2014
Q4
$134K Sell
2,005
-146
-7% -$9.21K ﹤0.01% 1383
2014
Q3
$131K Sell
2,151
-699
-25% -$43.1K ﹤0.01% 1298
2014
Q2
$167K Buy
2,850
+833
+41% +$48.8K ﹤0.01% 1125
2014
Q1
$117K Buy
2,017
+327
+19% +$17.5K ﹤0.01% 1299
2013
Q4
$90K Buy
1,690
+170
+11% +$10.1K ﹤0.01% 1250
2013
Q3
$94K Buy
1,520
+400
+36% +$23.9K ﹤0.01% 1149
2013
Q2
$68K Buy
+1,120
New +$66.7K ﹤0.01% 1204

Other funds holding DGX

Creative Planning's DGX Position: Q1 2026 in Review

Creative Planning increased its Quest Diagnostics (DGX) stake by 14% in Q1 2026, buying an estimated $523K and bringing the position to 21,638 shares worth $4.24M. The position accounts for ﹤0.01% of the portfolio, ranked #1328.

Creative Planning first reported a position in DGX in Q2 2013 and has held it in 51 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Creative Planning held 21,638 shares of Quest Diagnostics worth $4.24M as of Q1 2026.
  • Creative Planning bought 2,693 Quest Diagnostics shares in Q1 2026, an estimated $523K.
  • Quest Diagnostics made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #1328 holding.
  • Creative Planning first reported a position in Quest Diagnostics in Q2 2013 and has held it in 51 quarters since.
  • 1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.